Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers

Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers

Approximately 30–40% of male and 8–16% of female carriers of the Fragile X premutation will develop a neurodegenerative movement disorder characterized by intentional tremor, gait ataxia, autonomic dysfunction, cognitive decline, and Parkinsonism during their lifetime. At the molecular level, premut...

Full description

Bibliographic Details
Main Authors: Reem R. Al Olaby, Hiu-Tung Tang, Blythe Durbin-Johnson, Andrea Schneider, David Hessl, Susan M. Rivera, Flora Tassone
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Genetics
Subjects:
FMR1
ASFMR1
transcription
premutation
FXTAS
CATSYS
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2018.00302/full

Internet

https://www.frontiersin.org/article/10.3389/fgene.2018.00302/full

Similar Items